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Carcinogenic embryonic antigen (CEA) titers were determined for 611 Michigan farmers exposed to
PBB and a control nonexposed population of 138 Wisconsin farmers.
The overall prevalence ofelevated CEA titers was slightly higher in the Michigan study group, but the
difference was not statistically significant. Smoking and/or significant past or present conditions (inflam-
matory bowel disease, ulcers, polyps, liver disease, chronic lung disease, or malignancies) were found to
result in higher prevalence ofelevated CEA titers, in both the Michigan study group and the Wisconsin
control group, thus confirming previous reports.
In addition, serum PBB concentrations appeared to be positively correlated with CEA titers. The
possibility that the effect ofPBB may be additive to that ofother factors which are known to result in an
increased prevalence of elevated CEA titers is discussed.
Carcinoembryonic antigent (CEA), when first
isolated and characterized in 1965 (1), was consid-
ered to be a specific marker for entodermally de-
rived tumors. Additional investigations found ele-
vated titers in a broad spectrum of both malignant
(2-4) and nonmalignant conditions (5-7). The po-
tential of CEA as a method for quick, noninvasive
mass screening for gastrointestinal tract tumors was
found to be limited because it soon appeared that
CEA reflected active disease processes of many
types, not only malignant ones. It is currently felt
that CEA represents a nonspecific material result-
ing from pathological cell changes which may occur
in a variety of tissues and may reflect the state of
cell de-differentiation. Clinically, CEA is used to
monitor cancer therapy results and as evidence for
early tumor recurrence of malignancies which have
been identified as producing CEA. Serial CEA titers
are used in such cases.
Whether an elevated CEA titer represents an in-
creased risk of having an undiagnosed illness or an
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increased risk of developing an illness is under in-
vestigation. One study has provided a suggestion
that this may be the case (8). As part ofan on-going
collaborative study with Hoffmann-LaRoche scien-
tists, the Environmental Sciences Laboratory is
evaluating CEA titers as possible indicators of
health risk, especially in occupational groups
known or suspected ofhaving toxic or carcinogenic
exposures.
The lack oforgan system specificity ofCEA pos-
sibly can be used to advantage. Different tissues
may be producing CEA independently and the re-
sulting titer could represent a summation of the ef-
fects of one toxic agent on several sites, or several
agents affecting the same or different organ sys-
tems. In this sense, CEA might represent an index
of multiple factor interaction. Environmental fac-
tors such as cigarette smoking, excessive alcohol
consumption, and occupational exposure to vinyl
chloride have been shown singly and in combination
to affect the distribution of CEA titers in popula-
tions (9).
CEA titer analysis was included in the Environ-
mental Sciences Laboratory's protocol for evalua-
tion of the health status of PBB-exposed Michigan
farm residents.
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Population
Farm family units as well as families which had
purchased farm produce directly from these farms
were invited to participate voluntarily in the survey
conducted November 4-11, 1976 in Grand Rapids,
Michigan. Individuals from quarantined and non-
quarantined farms were selected in a statistically
random manner. A subgroup of self-selected farm-
ers were also examined. A detailed discussion ofthe
selection methods is described by Anderson et al.
(10).
A comparison group of non-PBB-exposed
families which would have the same general farm
environmental exposures except for PBB was
sought. A comparable group of Wisconsin dairy
farmers was identified and examined.
Examination Protocols
History of current and past medical illness,
cigarette use, and current alcohol consumption
were obtained by a physician at the time of exami-
nation.
Included in the battery of laboratory studies per-
formed for adults (age 18 and over) was the CEA-
Roche titer (6). Sample collection and storage ma-
terials were those supplied by Hoffmann-LaRoche,
Inc. A4-ml portion ofEDTA plasma was frozen and
later transported to the company laboratories in
their Nutley, New Jersey research facility, where
sample analysis was performed without knowledge
as to the identity of the samples. The radioim-
munoassay used had a sensitivity of + 0.5 ng/ml.
Using this method, Hoffmann-LaRoche reports that
97% of normal, healthy, noncigarette smoking
adults have titers below 2.5 ng/ml (6).
Serum PBB analyses were performed using the
methods and procedures described by Wolff et al.
(11).
Statistics
A 2 x 2 chi-square test was used to test the sig-
nificance of differences in the prevalence of ele-
vated CEA titers in the populations studied.
Results
CEA titers were obtained on 611 of 626 adults in
the Michigan group, and 138 ofthe 156 adults in the
Wisconsin group. Table 1 summarizes the overall
distribution of CEA titers in the two populations.
Table 1. Distribution of CEA titers in the two populations tested.
CEA CEA CEA CEA
0-2.5 2.6-5.0 5.1-10 > 10
Study Total ng/ml ng/ml ng/ml ng/ml
group tested No. % No. % No. % No. %
Michigan 611 536 87.7 55 9 16 2.6 4 0.7
Wisconsin 138 129 93.5 8 5.8 1 0.7 0 0
Although the prevalence of titers greater than 2.5
ng/ml is higher in the Michigan group than the Wis-
consin one, the differences are not significant.
The possible effects of age on the titer distribu-
tion is examined in Table 2. A trend toward a
greater prevalence ofelevated titers in the older age
categories is present in both the Michigan and Wis-
consin groups. There is no statistically significant
difference among the Wisconsin age categories. The
Michigan ""less than 36 years ofage" category has a
significantly lower prevalence of elevated titers
than either ofthe other age categories (respectively,
2 = 6.1, p < 0.02, x2 = 5.1, p < 0.02).
In Table 3, the distribution ofCEA titers by sex is
summarized. In both populations, males had a
higher prevalence of elevated titers than females.
This difference is highly significant for the Michigan
group (X2 = 16.1,p <0.001).
In the collaborative study of Hansen et al. (6),
cigarette smoking was shown to affect CEA titer
distribution. We analyzed the results in the Michi-
gan and Wisconsin groups in relation to their
cigarette smoking habits. Table 4 summarizes the
comparison. In both groups, current cigarette
smokers had a significantly higher prevalence of
elevated CEA titers than nonsmokers (Michigan x2
= 40.7, p < 0.001, Wisconsin X2 = 11.3, p < 0.001).
Former smokers fell between the other categories.
In the two populations, former smokers were not
significantly different from the nonsmokers. Within
smoking categories, the Michigan and Wisconsin
populations did not differ.
Heavy alcohol consumption and alcoholic cir-
rhosis are associated with elevated CEA titers (7).
Seven individuals in our survey population regu-
larly consumed more than one quart ofwhisky or its
equivalent per week. Six of the seven had normal
CEA titers. Removal of the one individual result
(between 2.5 and 5 ng/ml) does not affect the results
of the analysis.
Previous history of, or currently active disease,
can cause elevations in the CEA titer (5). Table 5
groups the Michigan examinees by whether or not
they had ever been treated for inflammatory bowel
disease, ulcers, polyps, chronic lung disease, liver
disease, or malignancies. Individuals with histories
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CEA CEA CEA CEA
Age, Total 0-2.5 ng/ml 2.6-5 nglml 5.1-10 ng/ml > 10.1-ng/ml
years, Group examined No. % No. % No. % No. %
18-35 Michigan 286 262 91.5 20 7 4 1.5 0 0
Wisconsin 32 32 100 0 0 0 0 0 0
36-55 Michigan 228 193 84.6 22 9.6 10 4.4 3 1.3
Wisconsin 73 67 92 5 7.5 1 1.5 0 0
36+ Michigan 97 81 83.5 13 13.4 2 2.1 1 1.0
Wisconsin 34 31 91 3 9 0 0 0 0
Table 3. Distribution of CEA titers among Michigan and Wisconsin farmers by sex.
CEA CEA CEA CEA
Total 0-2.5 ng/ml 2.6-5 ng/ml 5.1-10 ng/ml < 10.1 ng/ml
Sex Group examined No. % No. % No. % No. %
Males Michigan 312 265 84.9 36 11.5 8 2.6 3 1.0
Wisconsin 76 70 92.1 5 6.6 1 1.3 0 0
Females Michigan 299 271 90.6 19 6.4 8 2.7 1 0.3
Wisconsin 62 59 95.2 3 4.8 0 0 0 0
Table 4. Distribution of CEA titers among Michigan and Wisconsin farmers by current cigarette use.
CEA CEA CEA CEA
Total 0-2.5 ng/ml 2.6-5 ng/ml 5.1-10 ng/ml > 10.1 ng/ml
Cigarette use Study group examined No. % No. % No. % No. %
Never Michigan 355 332 93.5 19 5.4 4 1.1 0 0
smoked
cigarettes Wisconsin 97 94 96.9 3 3.1 0 0 0 0
Former Michigan 103 91 88.4 8 7.8 2 1.9 2 1.9
cigarette
smokersa Wisconsin 25 23 92.0 2 8.0 0 0 0 0
Current Michigan 147 107 72.8 28 19.0 10 6.8 2 1.4
cigarette
smokers Wisconsin 16 12 75.0 3 18.8 1 6.2 0 0
a Ceased smoking more than one year age.
Table 5. Distribution of CEA titers among Michigan farmers by past history of medical illness.
CEA CEA CEA CEA
Past medical Total 0-2.5 ng/ml 2.6-5 ng/ml 5.1-10 ng/ml > 10.1 ng/ml
history examined No. % No. % No. % No. %
Negative 445 401 90.1 35 7.9 8 1.8 1 0.2
Positivea 166 135 81.3 20 12.0 8 4.8 3 1.8
a One or more of the following present in the past medical history: chronic bronchitis and/or emphysema; gastrointestinal disease,
ulcers, inflammatory bowel disease, polyps history of malignancy; other: cirrhosis, gall bladder disease, thyroid. The prevalence of
elevated CEA titers was significantly higher in the group with positive paft medical history (X2 = 8.7, p < 0.01).
of such disorders had a significantly higher preva-
lence of elevated CEA titers compared with those
without history of such diseases (X = 8.7,p < 0.01).
Examining the combined effect of current cigarette
smoking and abnormal medical histories, 16 of 54
(30%) had elevated CEA titers while in the
nonsmoker-normal medical history group, only 16
of 282 (6%) had elevated titers. A combined effect
of cigarette smoking and abnormal medical history
is clearly evident.
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CEA CEA CEA CEA
0-2.5 2.6-5.0 5.1-10 > 10
Total ng/ml ng/ml ng/ml ng/ml
Serum PBB level, ppb tested No. % No. % No. % No. %
Nondetected-0.2 16 16 100 0 0 0 0 0 0
>0.2-1.0 67 59 88 5 7.5 2 3.0 1 1.5
> 1.0-5.0 168 149 88.7 15 8.9 3 1.8 1 0.6
> 5.0-10.0 53 49 92.4 3 5.7 1 1.9 0 0
¢ 10.0 58 43 74.1 11 19.0 3 5.2 1 1.7
Table 7. Distribution of CEA titers in smokers in relation to serum PBB levels less than and greater than 10 ppb.a
CEA CEA CEA CEA
0-2.5 2.6-5.0 5.1-10 > 10
Serum Total ng/ml ng/ml ng/ml ng/ml
PBB level, ppb tested No. % No. % No. % No. %
< 10 83 63 75.9 14 16.9 5 16.0 1 1.2
a10 17 8 47.1 6 35.4 2 11.8 1 5.9
a The prevalence ofabnormal CEA titers (>2.5 ng/ml) is significantly greater in smokers (X2 = 5.70,p < 0.02) with serum PBB levels
greater than or equal to 10 ppb.
Of the 611 Michigan adults whose CEA titers
have been estimated, 362 have at this time had their
serum PBB concentrations determined. While
selection of samples for PBB analyses were ran-
domized, caution must be exercised in drawing
conclusions prior to the availability of all results.
Table 6 shows the distribution of CEA titers by
serum PBB levels. The prevalence ofelevated CEA
titers is significantly greater among individuals
with higher serum PBB levels (X2 = 13.0, df = 4,
p < 0.02). The largest incremental change occurred
at the 10 ppb serum PBB concentration.
We investigated the possible multiple factor in-
teraction of serum PBB levels and cigarette smok-
ing. Table 7 demonstrates that cigarette smokers
with serum PBB levels above 10 ppb have signifi-
cantly higher prevalence of elevated CEA titers
than cigarette smokers with lower serum PBB con-
centrations (x2 < 5.7, p < 0.02).
Discussion
CEA titers were determined for 611 Michigan
farmers exposed to PBB and acontrol population of
138 Wisconsin farmers. The overall prevalence of
elevated titers was slightly higher in the Michigan
study group than in Wisconsin, but the difference
did not approach statistical significance.
The results of this study are consistent with the
findings of other investigators. CEA titers may be
influenced by many different factors singly or in
combination. As others have found, cigarette
smoking and current and past medical illnesses can
significantly affect CEA titer distribution. In-
terpretation of individual titers must consider such
factors. These principally affect CEA titer eleva-
tions in the lower titer ranges (< 10 ng/ml), and such
levels should not be considered diagnostic ofmalig-
nancy.
Of the four individuals in our survey with titers
greater than 10 ng/ml, one was subsequently diag-
nosed as having a neoplasm and one had a recur-
rence of a previously diagnosed malignancy. The
other two are under observation.
The relationship of various population charac-
teristics of CEA titer distribution was investigated.
Comparing the groups by sex and age categories did
not show any significant differences, although
males in each group had higher prevalence of ele-
vated titers. The sex difference was, overall, more
pronounced in the Michigan population and reached
a p < 0.001 level of significance. Multiple factors
were probably responsible forthis difference. Males
tended to have a higher prevalence of cigarette
smoking, and when they smoked, did so more
heavily. Wolffet al. (11) found serum PBB concen-
trations to be higher among males tested. Further,
as demonstrated here, serum PBB affects CEA titer
and is additive to the effect of smoking. It is also
interesting to note that elevations of SGPT were
significantly more prevalent among Michigan males
than females (12). Further investigation ofthese in-
terrelationships will follow the completion of serum
and fat biopsy PBB analyses.
Age differences were also noted in both the
Michigan and Wisconsin examined populations.
One consideration which may be related to this
Environmental Health Perspectivesfinding would be that younger individuals have
fewer current medical problems, and ifthey smoke
cigarettes, have not smoked for as long a period.
Examining available data concerning serum PBB
concentrations, it appears there is an association
between CEA titers and serum PBB, and that the
effects of serum PBB are additive to other factors
discussed. Until completion of analysis of all
specimens, however, judgment on the significance
of this initial observation should be held in
abeyance.
CEA titer distribution appears to be associated
with general health status as reflected by the factors
reviewed and known to be associated with disease.
Environmental agents such as cigarette smoke,
PBB, and occupational exposure to vinyl chloride
also influence titer distribution, although the
mechanisms by which various agents do this need
further study. Serial studies of CEA titers in the
PBB-exposed farmers, and prospective observation
will allow further assessment ofwhether individuals
with elevated titers have a different health experi-
ence than those with lower titers.
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